Recombinant human TSH for the treatment of differentiated thyroid cancer metastatic to the spine

The diagnostic use of recombinant human TSH (rhTSH) in follow- up of differentiated thyroid cancer (DTC) is already approved, however its application in (131)I therapy is still to be evaluated. We report results obtained in four patients with DTC metastatic to central skeleton, in whom 5 courses of...

Full description

Saved in:

Bibliographic Details
Published in:	Nuclear medicine review. Central & Eastern Europe Vol. 3; no. 2; pp. 157 - 160
Main Authors:	Jarzab, B, Roskosz, J, Gawkowska-Suwińska, M, Turska, M, Handkiewicz-Junak, D, Puch, Z, Wygoda, Z, Zajusz, A
Format:	Journal Article
Language:	English
Published:	Poland 2000
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The diagnostic use of recombinant human TSH (rhTSH) in follow- up of differentiated thyroid cancer (DTC) is already approved, however its application in (131)I therapy is still to be evaluated. We report results obtained in four patients with DTC metastatic to central skeleton, in whom 5 courses of rtTSH aided 131I therapy were administered.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	1506-9680